Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders
Status:
Unknown status
Trial end date:
2018-12-15
Target enrollment:
Participant gender:
Summary
Escitalopram has been approved by FDA in the treatment of adolescents with major depressive
disorder since March 2009. To date, there are only 3 clinical trials assessing the effect and
validity of escitalopram on major depressive disorder, which of them has resulted in
inconsistent findings. In the present study, the authors aimed to assess the effect and
validity of this drug in the treatment of adolescents with major depressive disorder and or
anxiety disorders.